Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Simuni, T.; Uribe, L.; Cho, H. R.; Caspell-Garcia, C.; Coffey, C. S; Siderowf, A. & Trojanowski, J. Q et al. (2020)
The Lancet Neurology, 19(1) pp. 71-80. DOI: https://doi.org/10.1016/S1474-4422(19)30319-9
